Life sciences organizations are eager to embrace artificial intelligence (AI) for the advantages it promises in productivity, disruption, innovation, and customer experience. Increases in these areas, for example, can result in shortened time-to-market for new pharmaceutical products, which can give patients earlier access to potentially life-altering health benefits.
AI can have a profound effect across the entire life sciences value chain — from research and development to commercialization and manufacturing. This white paper helps readers determine how to prioritize and quantify impactful AI use cases and offers examples of AI-powered life sciences use cases with high ROI potential.
The post Overcome AI adoption barriers in life sciences: A path to ROI appeared first on Whitepaper Repository -.
↧